These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12447792)

  • 1. [The pharmacological approach to the autistic spectrum].
    Morant A; Mulas F; Hernández S
    Rev Neurol; 2002 Feb; 34 Suppl 1():S64-7. PubMed ID: 12447792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders.
    Posey DJ; McDougle CJ
    Harv Rev Psychiatry; 2000; 8(2):45-63. PubMed ID: 10902094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted treatments for symptom domains in child and adolescent autism.
    Hollander E; Phillips AT; Yeh CC
    Lancet; 2003 Aug; 362(9385):732-4. PubMed ID: 12957098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of aggression in children and adolescents with autism and conduct disorder.
    McDougle CJ; Stigler KA; Posey DJ
    J Clin Psychiatry; 2003; 64 Suppl 4():16-25. PubMed ID: 12672261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic treatment of autism.
    Palermo MT; Curatolo P
    J Child Neurol; 2004 Mar; 19(3):155-64. PubMed ID: 15119475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication treatment in subjects with autistic spectrum disorders.
    Buitelaar JK; Willemsen-Swinkels SH
    Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I85-97. PubMed ID: 11140783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enuresis with combined risperidone and SSRI use.
    Took KJ; Buck BJ
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):840-1. PubMed ID: 8768340
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacotherapy of children and adolescents with pervasive developmental disorders.
    Hanft A; Hendren RL
    Essent Psychopharmacol; 2004; 6(1):12-24. PubMed ID: 15612651
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacologic treatment for the core deficits and associated symptoms of autism in children.
    West L; Waldrop J; Brunssen S
    J Pediatr Health Care; 2009; 23(2):75-89. PubMed ID: 19232924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open trial of divalproex sodium in autism spectrum disorders.
    Hollander E; Dolgoff-Kaspar R; Cartwright C; Rawitt R; Novotny S
    J Clin Psychiatry; 2001 Jul; 62(7):530-4. PubMed ID: 11488363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapeutic management of autism.
    Posey DJ; McDougle CJ
    Expert Opin Pharmacother; 2001 Apr; 2(4):587-600. PubMed ID: 11336609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of autistic disorder.
    Campbell M; Schopler E; Cueva JE; Hallin A
    J Am Acad Child Adolesc Psychiatry; 1996 Feb; 35(2):134-43. PubMed ID: 8720622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The status of pharmacotherapy for autism spectrum disorders.
    Myers SM
    Expert Opin Pharmacother; 2007 Aug; 8(11):1579-603. PubMed ID: 17685878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antipsychotics, anticonvulsants, antiadrenergics and other drugs: what to do when posttraumatic stress disorder does not respond to selective serotonin reuptake inhibitors?].
    Berger W; Portella CM; Fontenelle LF; Kinrys G; Mendlowicz MV
    Braz J Psychiatry; 2007 Oct; 29 Suppl 2():S61-5. PubMed ID: 18157435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy in children and adolescents with pervasive developmental disorders.
    Scahill L; Koenig K
    J Child Adolesc Psychiatr Nurs; 1999; 12(1):41-3. PubMed ID: 10347430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of selective serotonin reuptake inhibitors in autism and related disorders.
    Posey DJ; Erickson CA; Stigler KA; McDougle CJ
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):181-6. PubMed ID: 16553538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of treatment with fluvoxamine, a selective serotonin reuptake inhibitor in children with autistic disorder].
    Fukuda T; Sugie H; Ito M; Sugie Y
    No To Hattatsu; 2001 Jul; 33(4):314-8. PubMed ID: 11494573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Children and autism--Part 1--recognition and pharmacological management.
    Angley M; Young R; Ellis D; Chan W; McKinnon R
    Aust Fam Physician; 2007 Sep; 36(9):741-4. PubMed ID: 17915375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug fails to subdue repetitive behavior in children with autism spectrum disorders.
    Harv Ment Health Lett; 2009 Oct; 26(4):7. PubMed ID: 19904836
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychopharmacology of autistic spectrum disorders in children and adolescents.
    Nazeer A
    Pediatr Clin North Am; 2011 Feb; 58(1):85-97, x. PubMed ID: 21281850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.